Literature DB >> 25229405

Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.

Daniel J Barrera1, Julian N Rosenberg, Joanna G Chiu, Yung-Nien Chang, Michelle Debatis, Soo-Mun Ngoi, John T Chang, Charles B Shoemaker, George A Oyler, Stephen P Mayfield.   

Abstract

We have produced three antitoxins consisting of the variable domains of camelid heavy chain-only antibodies (VH H) by expressing the genes in the chloroplast of green algae. These antitoxins accumulate as soluble proteins capable of binding and neutralizing botulinum neurotoxin. Furthermore, they accumulate at up to 5% total soluble protein, sufficient expression to easily produce these antitoxins at scale from algae. The genes for the three different antitoxins were transformed into Chlamydomonas reinhardtii chloroplasts and their products purified from algae lysates and assayed for in vitro biological activity using toxin protection assays. The produced antibody domains bind to botulinum neurotoxin serotype A (BoNT/A) with similar affinities as camelid antibodies produced in Escherichia coli, and they are similarly able to protect primary rat neurons from intoxication by BoNT/A. Furthermore, the camelid antibodies were produced in algae without the use of solubilization tags commonly employed in E. coli. These camelid antibody domains are potent antigen-binding proteins and the heterodimer fusion protein containing two VH H domains was capable of neutralizing BoNT/A at near equimolar concentrations with the toxin. Intact antibody domains were detected in the gastrointestinal (GI) tract of mice treated orally with antitoxin-producing microalgae. These findings support the use of orally delivered antitoxins produced in green algae as a novel treatment for botulism.
© 2014 Society for Experimental Biology, Association of Applied Biologists and John Wiley & Sons Ltd.

Entities:  

Keywords:  algae; biotechnology; chloroplast; neurotoxin; recombinant protein

Mesh:

Substances:

Year:  2014        PMID: 25229405      PMCID: PMC4620920          DOI: 10.1111/pbi.12244

Source DB:  PubMed          Journal:  Plant Biotechnol J        ISSN: 1467-7644            Impact factor:   9.803


  19 in total

1.  Translational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobacco.

Authors:  Ezequiel M Lentz; Lorena Garaicoechea; E Federico Alfano; Viviana Parreño; Andrés Wigdorovitz; Fernando F Bravo-Almonacid
Journal:  Planta       Date:  2012-04-24       Impact factor: 4.116

Review 2.  Single-domain antibodies as building blocks for novel therapeutics.

Authors:  Dirk Saerens; Gholamreza Hassanzadeh Ghassabeh; Serge Muyldermans
Journal:  Curr Opin Pharmacol       Date:  2008-08-22       Impact factor: 5.547

3.  Synthetic oligonucleotide libraries reveal novel regulatory elements in Chlamydomonas chloroplast mRNAs.

Authors:  Elizabeth A Specht; Stephen P Mayfield
Journal:  ACS Synth Biol       Date:  2012-10-31       Impact factor: 5.110

4.  Improved heterologous protein expression in the chloroplast of Chlamydomonas reinhardtii through promoter and 5' untranslated region optimization.

Authors:  Beth A Rasala; Machiko Muto; Joseph Sullivan; Stephen P Mayfield
Journal:  Plant Biotechnol J       Date:  2011-05-02       Impact factor: 9.803

5.  Production of unique immunotoxin cancer therapeutics in algal chloroplasts.

Authors:  Miller Tran; Christina Van; Daniel J Barrera; Pär L Pettersson; Carlos D Peinado; Jack Bui; Stephen P Mayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

6.  Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

Authors:  Kwang-Chul Kwon; Ramya Nityanandam; James S New; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2012-10-18       Impact factor: 9.803

7.  Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.

Authors:  James A Gregory; Aaron B Topol; David Z Doerner; Stephen Mayfield
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

8.  Antibody protection against botulinum neurotoxin intoxication in mice.

Authors:  Luisa W Cheng; Larry H Stanker; Thomas D Henderson; Jianlong Lou; James D Marks
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

9.  Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.

Authors:  James A Gregory; Fengwu Li; Lauren M Tomosada; Chesa J Cox; Aaron B Topol; Joseph M Vinetz; Stephen Mayfield
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

10.  A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model.

Authors:  Jean Mukherjee; Jacqueline M Tremblay; Clinton E Leysath; Kwasi Ofori; Karen Baldwin; Xiaochuan Feng; Daniela Bedenice; Robert P Webb; Patrick M Wright; Leonard A Smith; Saul Tzipori; Charles B Shoemaker
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

View more
  12 in total

Review 1.  Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.

Authors:  Yong Min Kwon; Kyung Woo Kim; Tae-Young Choi; Sun Young Kim; Jaoon Young Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-11-26       Impact factor: 3.312

Review 2.  Harnessing the Algal Chloroplast for Heterologous Protein Production.

Authors:  Edoardo Andrea Cutolo; Giulia Mandalà; Luca Dall'Osto; Roberto Bassi
Journal:  Microorganisms       Date:  2022-03-30

3.  Selenocystamine improves protein accumulation in chloroplasts of eukaryotic green algae.

Authors:  Livia S Ferreira-Camargo; Miller Tran; Joris Beld; Michael D Burkart; Stephen P Mayfield
Journal:  AMB Express       Date:  2015-07-03       Impact factor: 3.298

4.  From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein.

Authors:  Franziska Hempel; Michael Maurer; Björn Brockmann; Christian Mayer; Nadine Biedenkopf; Anne Kelterbaum; Stephan Becker; Uwe G Maier
Journal:  Microb Cell Fact       Date:  2017-07-27       Impact factor: 5.328

Review 5.  Prospects on the Use of Schizochytrium sp. to Develop Oral Vaccines.

Authors:  Abel Ramos-Vega; Sergio Rosales-Mendoza; Bernardo Bañuelos-Hernández; Carlos Angulo
Journal:  Front Microbiol       Date:  2018-10-25       Impact factor: 5.640

6.  New tools for chloroplast genetic engineering allow the synthesis of human growth hormone in the green alga Chlamydomonas reinhardtii.

Authors:  Thanyanan Wannathong; Janet C Waterhouse; Rosanna E B Young; Chloe K Economou; Saul Purton
Journal:  Appl Microbiol Biotechnol       Date:  2016-02-18       Impact factor: 4.813

7.  Utilizing genome-scale models to optimize nutrient supply for sustained algal growth and lipid productivity.

Authors:  Chien-Ting Li; Jacob Yelsky; Yiqun Chen; Cristal Zuñiga; Richard Eng; Liqun Jiang; Alison Shapiro; Kai-Wen Huang; Karsten Zengler; Michael J Betenbaugh
Journal:  NPJ Syst Biol Appl       Date:  2019-09-24

Review 8.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

9.  Genome analysis and genetic transformation of a water surface-floating microalga Chlorococcum sp. FFG039.

Authors:  Yoshiaki Maeda; Daisuke Nojima; Miki Sakurai; Tatsuhiro Nomaguchi; Momoko Ichikawa; Yuki Ishizuka; Tsuyoshi Tanaka
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

Review 10.  The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.

Authors:  Sergio Rosales-Mendoza; Ileana García-Silva; Omar González-Ortega; José M Sandoval-Vargas; Ashwini Malla; Sornkanok Vimolmangkang
Journal:  Molecules       Date:  2020-09-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.